1.
J Dermatolog Treat
; 34(1): 2174786, 2023 12.
Artículo
en Inglés
| MEDLINE
| ID: mdl-36715364
2.
Dermatol Ther
; 35(6): e15497, 2022 06.
Artículo
en Inglés
| MEDLINE
| ID: mdl-35388597
3.
Cancers (Basel)
; 13(13)2021 Jul 03.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34283060
RESUMEN
Diffuse large B-cell lymphomas (DLBCLs) are aggressive B-cell neoplasms with considerable clinical, biologic, and pathologic diversity. The application of high throughput technologies to the study of lymphomas has yielded abundant molecular data leading to the identification of distinct molecular identities and novel pathogenetic pathways. In light of this new information, newly refined diagnostic criteria have been established in the fourth edition of the World Health Organization (WHO) consensus classification of lymphomas, which was revised in 2016. This article reviews the histopathological and molecular features of the various aggressive B-cell lymphoma subtypes included in the updated classification.